TickerGuard
Buy Day today: Poor (44) Weak market breadth · today: Core PCE (August) ≈
NEOG

Neogen Corporation

Healthcare · Medical Devices

13.60$ -2.9% vs. previous close Closing price · As of: Sep 23, 2026

Statements

Balance Sheet

Neogen Corporation (NEOG) by the numbers: income statement, balance sheet and cash flow, by year or by quarter. In the most recent period (Q2 26), "Total Assets" came in at 3,346 million USD. Tick rows to compare them in a chart.

Income Statement Balance Sheet Cash Flow Ratios
Annual Quarterly
Amounts Change % Common size %
Last 12 Full history
Download as CSV

All figures in millions of USD.

Tick rows to compare them in a chart (up to 4)

Balance Sheet NEOG
Line item Q3 16 Q4 16 Q1 17 Q2 17 Q3 17 Q4 17 Q1 18 Q2 18 Q3 18 Q4 18 Q1 19 Q2 19 Q3 19 Q4 19 Q1 20 Q2 20 Q3 20 Q4 20 Q1 21 Q2 21 Q3 21 Q4 21 Q1 22 Q2 22 Q3 22 Q4 22 Q1 23 Q2 23 Q3 23 Q4 23 Q1 24 Q2 24 Q3 24 Q4 24 Q1 25 Q2 25 Q3 25 Q4 25 Q1 26 Q2 26
469 487 507 528 547 581 596 618 641 660 673 696 721 751 774 797 822 846 880 920 932 967 980 993 977 4,563 4,509 4,554 4,561 4,602 4,582 4,584 4,503 4,054 4,036 3,444 3,378 3,360 3,359 3,346
269 288 277 293 311 340 352 376 396 414 423 450 474 500 515 537 557 578 555 591 609 610 608 627 608 643 555 586 584 624 602 589 541 570 552 577 524 575 590 605
76 86 60 78 58 64 82 83 97 102 94 42 56 66 51 66 61 114 73 76 71 51 43 44 107 100 67 163 179 206 161 171 120 140 128 129 139 145 160 186
129 142 125 144 160 176 192 211 226 241 247 268 291 314 328 344 367 391 353 381 401 389 378 381 348 276 183 246 239 230 168 171 120 140 128 129 139 145 160 186
59 65 67 69 66 75 73 79 78 82 80 83 79 85 81 85 78 80 87 92 87 92 93 100 93 143 146 153 138 150 174 173 168 164 160 153 138 132 137 147
70 72 75 73 73 74 78 76 79 79 85 86 88 86 89 95 98 93 99 101 102 107 113 122 129 136 144 134 141 161 182 189 199 198 205 191 193 163 162 144
55 56 61 62 63 67 73 73 73 74 76 75 75 77 78 79 82 84 98 100 100 101 105 111 121 148 165 199 236 – – – – – – – – – – –
88 88 104 105 105 104 99 100 103 103 104 104 103 104 110 110 112 112 133 131 130 143 150 143 140 2,122 2,135 2,137 2,138 2,138 2,136 2,136 2,137 1,673 1,672 1,065 1,066 1,046 1,048 1,047
57 56 65 69 68 70 71 70 69 69 69 68 70 70 70 67 71 70 93 92 89 109 112 108 103 1,642 1,634 1,605 1,588 1,565 1,540 1,512 1,490 1,463 1,439 1,410 1,389 1,359 1,342 1,318
51 53 56 57 60 60 54 58 59 58 53 58 61 60 62 72 70 68 73 80 77 102 106 106 94 1,457 1,383 1,420 1,415 1,455 1,436 1,440 1,368 1,385 1,376 1,373 1,260 1,255 1,257 1,253
33 34 35 36 38 38 37 39 39 39 34 38 40 39 39 48 46 45 46 54 51 63 66 78 67 153 107 145 138 177 158 154 123 151 141 174 146 147 151 158
– – – – – – – – – – – – – 0.6 0.3 1.1 0.8 0.4 0.1 1.3 – – – 1.4 – – – 3.3 2.6 2.6 2.5 7.5 2.7 2.6 2.7 27 0.8 – – –
18 17 17 16 17 17 20 21 21 21 19 19 18 20 19 26 23 21 23 24 22 34 24 35 27 79 60 77 90 112 90 83 61 80 72 80 77 63 75 79
2.2 2.3 3.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 – – – – – – – – – – – – – – – 924 885 885 886 887 888 888 889 890 891 875 793 793 793 794
417 435 452 472 487 521 542 560 582 602 620 638 660 691 712 725 752 777 808 840 855 865 876 887 884 3,106 3,126 3,134 3,146 3,148 3,146 3,144 3,135 2,669 2,660 2,071 2,119 2,104 2,102 2,093
262 273 283 296 308 325 341 359 374 390 403 419 434 450 462 479 495 510 524 540 557 568 573 588 593 551 559 565 567 563 561 556 543 87 76 -536 -500 -516 -533 -544
102 102 103 103 103 104 104 106 106 104 105 105 105 105 106 106 107 106 107 108 108 108 108 108 108 220 216 216 217 216 217 217 217 217 217 217 217 217 218 218

Showing the most recent 40 periods — older statements are on file for this stock.

Data as of: September 23, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)

Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.

Was this page helpful to you?